Document:

EX-10.1

Exhibit 10.1

Compensation Arrangements for Non-Employee Directors of Genitope Corporation

Cash Fees (Effective July 1, 2005)

Each non-employee director is paid an annual retainer of $25,000, payable quarterly in advance
(January 1, April 1, July 1 and October 1).

Stock Option Grants 

Each non-employee director receives an annual option grant to purchase 10,000 shares of
Genitope Corporation common stock from the 2003 Non-Employee Directors’ Stock Option Plan (the
“Directors’ Plan”). The option grant is automatically awarded after the annual meeting of
stockholders each year. All stock option grants have an exercise price equal to the fair market
value on the grant date (determined as the closing price on the preceding business day) of a share
of common stock, a term of ten years and become exercisable and vest monthly over three years from
the date of grant. If a non-employee director has been a director for less than 12 months at the
time of the annual meeting of stockholders, then he or she will receive an annual grant that has
been reduced pro rata for each quarter prior to the date of grant during which such person did not
serve as a non-employee director.

Under the Directors’ Plan, a non-employee director joining the Board of Directors receives an
initial option grant to purchase 25,000 shares of Common Stock, on the same terms and conditions as
described in the previous paragraph.

Travel Expense Reimbursement

Non-employee directors are entitled to reimbursement of their reasonable travel expenses for
attending Board of Directors and Board Committee meetings.EX-10.1

Exhibit 10.1

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of June 6, 2005
(the “Effective Date”) among WellCare Health Plans, Inc. a Delaware corporation (“WellCare”),
Comprehensive Health Management, Inc., a Florida corporation and, as of the date hereof, an
indirect wholly-owned subsidiary of WellCare (the “Company”), and Todd S. Farha (the “Executive”).

WHEREAS, WellCare, the Company and the Executive are parties to that certain Amended and
Restated Employment Agreement, dated as of June 28, 2004 (the “Original Employment Agreement”); and

WHEREAS, the parties hereto wish to amend and restate the Original Employment Agreement as set
forth herein.

NOW, THEREFORE, in consideration of the mutual covenants and representations contained herein,
and intending to be legally bound, the parties hereto agree as follows:

1. Term.

The Company will employ the Executive, and the Executive will serve the Company, under the
terms of this Agreement for an initial term (the “Term”) of five years, commencing on the Effective
Date. Effective as of the expiration of such initial five-year Term and as of each one-year
anniversary date thereof, the Term shall be extended for an additional one-year period unless, not
later than three months prior to such respective date, either party hereto shall have given notice
to the other that the Term shall not be so extended (a “Notice of Non-Renewal”). Notwithstanding
the foregoing, the Executive’s employment by the Company may be terminated prior to the completion
of the then Term, as provided in Section 4 hereof. The period beginning on the Effective Date and
ending on the first to occur of (i) the last day of the Term and (ii) the date the Executive ceases
to be a full-time employee of the Company for any reason shall be referred to herein as the
“Employment Period.” In the event a Notice of Non-Renewal is delivered by either party as provided
above, then, as of the end of the Term, unless the Executive is no longer an employee of the
Company as of such time, the Executive shall become an at-will employee of the Company.

2. Employment.

(a) Positions and Reporting. The Company hereby employs the Executive for the
Employment Period as its Chief Executive Officer on the terms and conditions set forth in this
Agreement. During the Employment Period, the Executive shall also be Chief Executive Officer of
WellCare. During the Employment Period, the Executive shall report directly to and shall be
subject to the authority of the Board of Directors of WellCare (the “Board”).

(b) Authority and Duties.

(i) The Executive shall exercise such authority, perform such executive duties and functions
and discharge such responsibilities as are reasonably associated with and required by the
Executive’s position as Chief Executive Officer of WellCare and the Company, commensurate with the
authority vested in the Executive pursuant to this Agreement and consistent with the By-Laws of
WellCare and the Company. During the Employment Period, the Executive shall devote his full
business time, skill and efforts to the business and affairs of WellCare and its subsidiaries
(including the Company) whether currently existing or hereafter acquired or formed (collectively,
the “WellCare Companies”). Executive shall perform his duties and responsibilities to the best of
his abilities in a diligent, trustworthy, businesslike and efficient manner. Notwithstanding the
foregoing, subject to Section 8 hereof, the Executive may (A) make and manage personal passive
business investments of his choice and serve in any director or similar type capacity with up to
three civic, educational or charitable organizations, or any trade association, without seeking or
obtaining approval by the Board; (B) continue his ownership of (but not the management of)
Northeast Mobile Systems LLC (“NMS”), provided such activities described in (A) and (B) above do
not materially interfere or conflict with the performance of his duties hereunder, and (C) with the
approval of the Board, serve on the boards of directors of other corporations. The Executive
hereby agrees that he shall not use any WellCare Company, any business relationship of any WellCare
Company, or his position with any WellCare Company for the benefit of NMS.

(ii) The Executive shall serve as a member of the Board during the Employment Period.

(c) Place of Performance. The Executive’s primary work locations during the
Employment Period shall be the metropolitan areas of Tampa, Florida and New York City, New York;
provided, however, that the Executive shall be expected to undertake other
reasonable travel on WellCare Companies’ business.

3. Compensation and Benefits.

(a) Salary. During the Employment Period, the Company shall pay to the Executive, as
compensation for the performance of his duties and obligations under this Agreement, a base salary
at the rate of $400,000 per annum, payable in arrears not less frequently than monthly in
accordance with the normal payroll practices of the Company (the “Base Salary”). Such Base Salary
shall be subject to review each calendar year for possible increase by the Board in its sole
discretion, but shall in no event be decreased from its then-existing level during the Employment
Period.

(b) Annual Bonus. The Executive shall earn bonus amounts for each fiscal year of the
WellCare Companies (or part thereof) during the Employment Period, payable in the form of cash, to
be paid to the Executive within 10 days after the Board has received and approved the WellCare
Companies’ audited financial statements for such fiscal year. The determination of the bonus
amount for any such fiscal year (or part thereof) shall be based upon the satisfaction of
performance criteria for such fiscal year that will be established by the compensation committee of
the Board (the “Compensation Committee”) (or the full Board, if no such committee shall exist) in
its discretion and upon consultation with the Executive by no later than 30 days after the Board
has approved the WellCare Companies’ budget for such fiscal year. Such performance criteria will
include corporate performance goals consistent with the WellCare Companies’ business plan and
budget for such fiscal year, as well as individual objectives for the Executive’s performance that
are separate from, but are consistent with, such WellCare Companies’ business plan and budget. The
final determinations as to the actual corporate and individual performance against the
pre-established goals and objectives, and the amounts of the bonus payout in relationship to such
performance, shall be made by the Compensation Committee (or Board, as applicable) in its sole
discretion.

(c) Insurance Policies. The Company shall maintain in force during the Employment
Period, for up to an annual premium amount of $5,000, life and disability insurance on the
Executive, the beneficiary of which shall be designated by the Executive (the “Executive
Policies”). In the event that the Company cancels the Executive Policies (whether or not in breach
of this Agreement), the Executive shall have the option to continue them in force at his own
expense. Subject to insurability, the Executive Policies shall be assigned to the Executive upon
the termination of Executive’s employment with the Company. The Company (or any of the other
WellCare Companies) may also purchase “key-person” life insurance policies on the Executive’s life
in such amounts and of such types as are determined by the Board. The Executive shall cooperate
fully with the Company in obtaining such insurance and shall submit to such physical examinations
and provide such information as is reasonably required to obtain and maintain such policies.
Neither the Executive nor his successor-in-interest or estate shall have any interest in any such
key-person life insurance policies so obtained.

(d) Other Benefits. During the Employment Period, the Executive shall receive such
other pension, health insurance, holiday, vacation and sick pay benefits and other employee
benefits (including participation in any deferred compensation or other incentive plans) which the
Company extends, as a matter of policy, to its executive employees. Without limiting the
generality of the foregoing, the Executive shall be entitled to four weeks vacation during each
full calendar year of the Employment Period (which vacation benefits shall be appropriately pro
rated for any partial calendar year during the Employment Period), which vacation shall be
scheduled in the Executive’s discretion, subject to and taking into account the business exigencies
of WellCare Companies

(e) Business Expenses. The Company shall promptly reimburse the Executive for all
documented reasonable business and travel expenses incurred by the Executive in the performance of
his duties hereunder in accordance with the Company’s standard policies and practices.

(f) Travel Expenses; Housing and Automobile Allowance. Without limiting the
generality of Section 3(e), the Company shall reimburse the Executive for all reasonable expenses
incurred by him in connection with his travel during the Employment Period between the Company’s
principal service areas of Florida and New York. In addition, during the Employment Period, the
Company shall pay directly up to $4,000 per month of the cost of Executive’s living expenses in New
York, New York.

4. Termination of Employment Prior to the Expiration of the Term.

Executive’s employment with the Company may be terminated prior to the expiration of the Term
in any of the following ways:

(a) Termination Upon Death or Disability. The Employment Period shall end upon the
death of the Executive. In the event of the Disability (as hereinafter defined) of the Executive
during the Term, the Company shall have the right to terminate the Executive’s employment with the
Company by giving 30-days’ advance written notice to that effect to the Executive. For purposes of
this Agreement, the term “Disability” means any physical or mental disability or incapacity that
can be expected to result in death or that has rendered the Executive unable to effectively carry
out his duties and obligations to the WellCare Companies or unable to effectively and actively
participate in the management of the WellCare Companies for a period of 90 consecutive days or for
shorter periods aggregating to 120 days (whether or not consecutive) during any consecutive 12
months of the Employment Period.

(b) Termination for Cause. Prior to the expiration of the Term, the Company may
terminate the Executive’s employment with the Company for Cause (as hereinafter defined). For
purposes of this Agreement and subject to the Executive’s opportunity to cure as provided in
Section 4(e) hereof, the Company shall have “Cause” to terminate the Executive’s employment
hereunder if the Executive shall commit any of the following:

(i) any act or omission, other than as a result of the Executive’s Disability, which shall
represent a breach in any material respect of any of the terms of this Agreement;

(ii) bad faith in the performance of the Executive’s duties, consisting of willful acts or
omissions, other than as a result of the Executive’s Disability, to the material detriment of any
WellCare Company; or

(iii) any conviction or pleading of guilty to a crime that constitutes a felony or that
involves financial misconduct under the laws of the United States or any political subdivision
thereof;

provided, however, that if a Change in Control (as defined in Section 5A hereof)
shall occur during the Term, then the foregoing clause (i) shall thereafter cease to constitute a
part of the definition of “Cause” hereunder; and provided, further, that any
purported termination by the Company of the Executive’s employment hereunder for Cause shall only
be effective upon the affirmative vote of directors constituting at least two-thirds of the then
aggregate number of votes of the current members of the full Board, after a duly constituted
meeting of the Board held to consider such matter, with reasonable advance notice to the Executive
that such Board meeting is to occur, and with an opportunity provided to the Executive to be
represented at such Board meeting with counsel.

(c) Without Cause. Prior to the expiration of the Term, the Company, effective upon
the date specified in the notice of such termination, may terminate the Executive’s employment with
the Company for any reason whatsoever. Prior to the expiration of the Term, the termination by the
Company of the Executive’s employment with the Company for any reason other than Cause, Disability
or death shall constitute a termination “Without Cause” hereunder.

(d) Termination for Good Reason. The Executive shall have the right at any time to
terminate the Executive’s employment with the Company for any reason. Prior to the expiration of
the Term, the termination by the Executive of the Executive’s employment with the Company for any
reason other than for Good Reason (as hereinafter defined) or death shall constitute a “Voluntary
Resignation by Executive” hereunder. For purposes of this Agreement and subject to the Company’s
opportunity to cure as provided in Section 4(e) hereof, the Executive shall have “Good Reason” to
terminate employment hereunder if such termination shall be the result of:

(i) a material diminution during the Employment Period in the Executive’s authority, duties or
responsibilities as set forth in Section 2 hereof;

(ii) the removal of the Executive from the Board, other than pursuant to his removal from the
Board for cause pursuant to a vote of the equityholders of WellCare or due to Executive’s
resignation from the Board;

(iii) a breach by the Company of any of the compensation and benefits provisions set forth in
Section 3 hereof;

(iv) a material breach by the Company of any material terms of this Agreement;

(v) a change in the Executive’s office location to a point more than 50 miles from the
Executive’s offices in Tampa, Florida or New York, New York.

(e) Notice and Opportunity to Cure. Notwithstanding the foregoing, prior to the
expiration of the Term, it shall be a condition precedent to the Company’s right to terminate the
Executive’s employment for Cause and the Executive’s right to terminate employment for Good Reason
that (i) the party seeking the termination shall first have given the other party written notice
stating with specificity the reason for the termination (“breach”) and (ii) if such breach is
susceptible of cure or remedy, a period of 30 days from and after the giving of such notice shall
have elapsed without the breaching party having substantially cured or remedied such breach during
such 30-day period, unless such breach cannot be cured or remedied within 30 days, in which case
the period for remedy or cure shall be extended for a reasonable time (not to exceed an additional
30 days) provided the breaching party has made and continues to make a diligent effort to effect
such remedy or cure.

5. Consequences of Termination of Employment Prior to the Expiration of the Term.

(a) Termination Without Cause or for Good Reason. In the event of the termination of
the Executive’s employment with the Company, either by the Company Without Cause or by the
Executive for Good Reason, in each case, prior to the expiration of the Term, (i) the Company shall
continue to pay the Executive his Base Salary for twelve months following the effective date of
such termination, (ii) on the date twelve months after the effective date of such termination, the
Company shall pay the Executive an amount equal to Executive’s target bonus (as determined by the
Compensation Committee of the Company’s Board of Directors) for the Company’s fiscal year in which
such termination occurs and (iii) the Company shall continue for 12 months (the “Separation
Period”), at the Company’s expense, coverage for the Executive (and his beneficiaries) under the
group medical care, disability and life insurance benefit plans or arrangements in which he is
participating at the time of termination, including, without limitation, the Executive Polices;
provided, however, that if such coverage is precluded by the terms of the Company’s
benefit or insurance policies, the Company shall make a cash payment to the Executive in an amount
sufficient to allow the Executive to obtain comparable benefits for such period; and
provided, further, that the Company’s obligation to provide such coverage shall be
terminated if the Executive obtains equivalent substitute coverage from another employer at any
time during the Separation Period.

(b) Termination Upon Disability. In the event of the termination of the Executive’s
employment hereunder by the Company on account of Disability prior to the expiration of the Term,
(i) the Company shall continue to pay the Executive his Base Salary for the shorter of (x) three
months following the effective date of such termination and (y) the then remainder of the Term and
(ii) the Company shall continue for three months, at the Company’s expense, coverage for the
Executive (and his beneficiaries) under the group medical care, disability and life insurance
benefit plans or arrangements in which he is participating at the time of termination, including,
without limitation, the Executive Polices; provided, however, that if such coverage
is precluded by the terms of the Company’s benefit or insurance policies, the Company shall make a
cash payment to the Executive in an amount sufficient to allow the Executive to obtain comparable
benefits for such period; and provided, further, that the Company’s obligation to
provide such coverage shall be terminated if the Executive obtains equivalent substitute coverage
from another employer at any time during such continuation period.

(c) Termination Upon Death. In the event of termination of the Executive’s employment
with the Company prior to the expiration of the Term on account of the Executive’s death, the
Company shall pay to the Executive’s heirs, estate or personal representatives under law, as
applicable, a lump sum cash payment equal to 3 months of the Executive’s Base Salary. The
Executive’s beneficiary or estate shall not be required to remit to the Company any payments
received pursuant to any Executive Policies.

(d) Voluntary Resignation by Executive or Termination With Cause. In the event of the
termination of the Executive’s employment hereunder by the Company for Cause or by Voluntary
Resignation by Executive, in each case, prior to the expiration of the Term, the Company shall have
no responsibility or obligation to make any payments or provided any benefits to the Executive
except to the extent provided in Section 5(e) hereof.

(e) Accrued Rights. Notwithstanding the foregoing provisions of this Section 5, in
the event of termination of the Executive’s employment with the Company for any reason, the Company
shall pay to or on behalf of the Executive all unpaid Base Salary accrued through the effective
date of termination and a lump sum cash payment for all unused vacation accrued by the Executive
through the effective date of termination, and the Company shall provide to or on behalf of the
Executive all payments and other benefits accrued for the Executive through the effective date of
termination under all equity arrangements, benefit plans, programs and arrangements in which the
Executive participated during the Employment Period.

(f) No Other Payment Obligations. Except as expressly provided in Sections 5(a)
through 5(e) above or as required by law, upon the date the Executive ceases to be employed by the
Company (i) all of Executive’s rights to salary, bonus and benefits hereunder shall cease and (ii)
no other severance or other compensation, or benefits shall be payable by any of the WellCare
Companies to Executive.

5A. Change in Control.

Notwithstanding anything to the contrary in this Agreement, if a “Change in Control” (as
defined below) occurs during the term of this Agreement, and if within two years following such
Change in Control either (1) the Company terminates Executive’s employment Without Cause or (2)
Executive terminates his employment for Good Reason, such termination shall be treated as a
termination Without Cause or for Good Reason in accordance with Section 5(a) hereof, except
that the Company shall continue to pay the Executive his Base Salary for 24 months
following the effective date of such termination.

For purposes of this Agreement, the term “Change in Control” means:

(i) The acquisition by any “person” or “group” (as defined in or pursuant to Sections 13(d)
and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (other than (A)
WellCare or any subsidiary thereof, (B) any employee benefit plan of WellCare or any subsidiary
thereof, or (C) TowerBrook Investors L.P. and/or its successors or affiliates), directly or
indirectly, as “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act) of securities
of WellCare representing more than fifty percent (50%) of either the then outstanding shares or the
combined voting power of the then outstanding securities of such entity;

(ii) Either a majority of the directors of WellCare elected at WellCare’s annual stockholders
meeting shall have been nominated for election other than by or at the direction of the “incumbent
directors” of WellCare, or the “incumbent directors” shall cease to constitute a majority of the
directors of WellCare. The term “incumbent director” shall mean any director who was a director of
WellCare on the date hereof and any individual who becomes a director of WellCare subsequent to the
date hereof and who is elected or nominated by or at the direction of at least two-thirds (2/3) of
the then incumbent directors;

(iii) The stockholders of WellCare approve (A) a merger, consolidation or other business
combination of such entity with any other “person” or “group” (as defined in or pursuant to
Sections 13(d) and 14(d) of the Exchange Act) or affiliate thereof, other than a merger or
consolidation that would result in the outstanding common stock of WellCare immediately prior
thereto continuing to represent (either by remaining outstanding or by being converted into common
stock of the surviving entity or a parent or affiliate thereof) more than fifty percent (50%) of
the outstanding common stock of WellCare or such surviving entity or a parent or affiliate thereof
outstanding immediately after such merger, consolidation or other business combination, or (B) a
plan of complete liquidation of WellCare or an agreement for the sale or disposition by WellCare of
all or substantially all of its assets (including if accomplished pursuant to the sale of shares of
equity securities (including by any consolidation, merger or reorganization) of one or more
subsidiaries of WellCare which collectively constitute all or substantially all of such entity’s
assets); or

(iv) Any other event or circumstance which is not covered by the foregoing subsections but
which the Board determines to affect control of WellCare and with respect to which the Board adopts
a resolution that the event or circumstance constitutes a Change in Control for purposes of this
Agreement.

5B. Parachute Payments.

(a) In the event that any payment or benefit received or to be received by the Executive (the
“Payments”) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise
Tax”), the Company shall pay to the Executive an additional amount (the “Gross-Up Payment”) such
that the net amount of Payments retained by the Executive shall be equal to the amount the
Executive would have retained if none of such Payments were subject to the Excise Tax. In
particular, the Company will timely pay to the Executive an amount equal to the Excise Tax on the
Payments, any interest, penalties or additions to tax payable by the Executive by reason of the
Executive’s filing income tax returns and making tax payments in a manner consistent with an
opinion of tax counsel selected by the Company and reasonably acceptable to the Executive (“Tax
Counsel”), and any federal, state and local income tax and Excise Tax upon the payments by the
Company to the Executive provided for by this Section 5B(a). Notwithstanding the foregoing
provisions of this Section 5B(a), in the event the amount of Payments subject to the Excise Tax
exceeds the product (“Parachute Payment Limit”) of 2.99 and the Executive’s applicable “base
amount” (as such term is defined for purposes of Section 4999 of the Code) by less than ten percent
(10%) of the Base Salary, the Executive shall be treated as having waived such rights with respect
to Payments designated by the Executive to the extent required such that the aggregate amount of
Payments subject to the Excise Tax is less than the Parachute Payment Limit. “Code” refers to the
Internal Revenue Code of 1986, as amended.

(b) The Company shall obtain an opinion of Tax Counsel that initially determines whether any
of the Payments will be subject to the Excise Tax and the amounts of such Excise Tax, which shall
serve as the basis for reporting Excise Taxes and federal, state and local income taxes on Payments
hereunder. For purposes of determining the amount of the Gross-Up Payment, the Executive shall be
deemed to pay federal income tax at the highest marginal rates of federal income taxation
applicable to individuals in the calendar year in which the Gross-Up Payment is to be made and
state and local income taxes at the highest marginal rates of taxation applicable to individuals as
are in effect in the state and locality of the Executive’s residence in the calendar year in which
the Gross-Up Payment is to be made, net of the maximum reduction in federal income taxes that can
be obtained from deduction of such state and local taxes, taking into account any limitations
applicable to individuals subject to federal income tax at the highest marginal rates.

(c) The Gross-Up Payments provided for in this Section 5B shall be made as to each Payment
upon the earlier of (i) the payment to the Executive of any such Payment or (ii) the imposition
upon the Executive or payment by the Executive of any Excise Tax or any federal, state or local
income tax on any payment pursuant to this Section 5B.

(d) If it is established pursuant to a final determination of a court or an Internal Revenue
Service proceeding or the opinion of Tax Counsel that the Excise Tax is less than the amount taken
into account under Section 5B hereof, the Executive shall repay to the Company within five days of
the Executive’s receipt of notice of such final determination or opinion the portion of the
Gross-Up Payment attributable to such reduction (plus the portion of the Gross-Up Payment
attributable to the Excise Tax and federal, state and local income tax imposed on the Gross-Up
Payment being repaid by the Executive if such repayment results in a reduction in Excise Tax or a
federal, state and local income tax deduction) plus any interest received by the Executive on the
amount of such repayment. If it is established pursuant to a final determination of a court or an
Internal Revenue Service proceeding or the opinion of Tax Counsel that the Excise Tax exceeds the
amount taken into account hereunder (including by reason of any payment the existence or amount of
which cannot be determined at the time of the Gross-Up Payment), the Company shall make an
additional Gross-Up Payment in respect of such excess within five days of the Company’s receipt of
notice of such final determination or opinion.

6. Confidentiality.

(a) The Executive acknowledges that, by reason of the Executive’s employment by the Company,
the Executive will have access to confidential information of the WellCare Companies (“Confidential
Information”). The Executive acknowledges that such Confidential Information is a valuable and
unique asset of the WellCare Companies and covenants that, both during and after the Employment
Period, the Executive will not disclose any Confidential Information to any Person (defined below)
(except as the Executive’s duties as an employee or director of any of the WellCare Companies may
require) without the prior written authorization of the Board. The obligation of confidentiality
imposed by this Section 6 shall not apply to Confidential Information that otherwise becomes known
to the public through no act of the Executive in breach of this Agreement or which is required to
be disclosed by court order or applicable law.

(b) All records, designs, business plans, financial statements, customer lists, manuals,
memoranda, lists, research and development plans, Intellectual Property and other property
delivered to or compiled by the Executive by or on behalf of any WellCare Company or its providers,
clients or customers that pertain to the business of any WellCare Company shall be and remain the
property of such WellCare Company and be subject at all times to its discretion and control.
Likewise, all correspondence, reports, records, charts, advertising materials and other similar
data pertaining to the business, activities, research and development, Intellectual Property or
future plans of any WellCare Company that is collected by the Executive shall be delivered promptly
to such WellCare Company without request by it upon termination of the Executive’s employment. For
purposes of this Section 6(b), “Intellectual Property” shall mean patents, copyrights, trademarks,
trade dress, trade secrets, other such rights, and any applications.

7. Inventions.

The Executive is hereby retained in a capacity such that the Executive’s responsibilities may
include the making of technical and managerial contributions of value to the WellCare Companies.
The Executive hereby assigns to the applicable WellCare Company all rights, title and interest in
such contributions and inventions made or conceived by the Executive alone or jointly with others
during the Employment Period which relate to the business of such WellCare Company. This
assignment shall include (a) the right to file and prosecute patent applications on such inventions
in any and all countries, (b) the patent applications filed and patents issuing thereon, and (c)
the right to obtain copyright, trademark or trade name protection for any such work product. The
Executive shall promptly and fully disclose all such contributions and inventions to the Company
and assist the Company or any other WellCare Company, as the case may be, in obtaining and
protecting the rights therein (including patents thereon), in any and all countries;
provided, however, that said contributions and inventions will be the property of
the applicable WellCare Company, whether or not patented or registered for copyright, trademark or
trade name protection, as the case may be. Notwithstanding the foregoing, no WellCare Company
shall not have any right, title or interest in any work product or copyrightable work developed
outside of work hours and without the use of any WellCare Company’s resources that does not relate
to the business of any WellCare Company and does not result from any work performed by the
Executive for any WellCare Company.

8. Unfair Competition.

(a) Scope of Covenant. The Executive agrees that during the Employment Period, and,
subject to Section 8(e) hereof, for the one-year period beginning on the last day of the Employment
Period, the Executive shall not, directly or indirectly, for himself or on behalf of or in
conjunction with any other person, company, partnership, business, group, venturer or other entity
(each, a “Person”), without the prior written consent of the Board:

(i) engage as an officer, director, shareholder, owner, partner, joint venturer, or in any
managerial capacity, whether as an employee, independent contractor, consultant or advisor (paid or
unpaid), or as a sales representative, or otherwise participate, in each case, in any business that
sells, markets, or provides any benefits or services, that are in direct competition with the
benefits or services provided by any WellCare Company within any state that any WellCare Company is
doing business (the “Territory”) at the time Executive ceases to be employed by the Company;

(ii) recruit, hire or solicit any employee or former employee of any WellCare Company or
encourage any employee of any WellCare Company to leave such WellCare Company’s employ, unless such
former employee has not been employed by such WellCare Company for a period in excess of six
months; provided, however, that the provisions of this clause (ii) shall not apply
to any member of the Executive’s immediate family;

(iii) call upon any Person who at that time is or, at any time after the date one year prior
to the date Executive ceases to be employed by the Company, has been a provider, customer or agent
of any WellCare Company for the purpose of soliciting or selling benefits or services in
competition with any WellCare Company within the Territory; or

(iv) request or advise any provider, customer or agent of any WellCare Company to withdraw,
curtail or cancel its business dealings with such WellCare Company;

provided, however, that nothing in this Section 8(a) shall be construed to preclude
the Executive from making an investment in the securities of any business enterprise whether or not
engaged in competition with a WellCare Company, to the extent that such securities are actively
traded on a national securities exchange or in the over-the-counter market in the United States or
on any foreign securities exchange; but only if such investment does not exceed two percent (2%) of
the outstanding voting securities of such enterprise; provided, that such permitted
activity shall not relieve the Executive from any other provisions of this Agreement. If at any
time during the one year period beginning on the last day of the Employment Period, Executive
desires to become an employee of a division of a competitor of the WellCare Companies which
division is itself not engaged in competition with the WellCare Companies, then Executive may
request that the Company grant him a waiver of the provisions of Section 8(a)(i) above with respect
to his employment by such division so that Executive may become an employee of such division
without violating the provisions of Section 8(a)(i) above, which waiver the Company (with the prior
approval of the Board) may grant (but shall be under no obligation to grant) to Executive in its
sole discretion.

(b) Reasonableness. It is agreed by the parties that the foregoing covenants in this
Section 8 impose a reasonable restraint on the Executive in light of the activities and business of
the WellCare Companies on the date of the execution of this Agreement and the current plans of the
WellCare Companies. The Executive acknowledges that the covenants in this Section 8 shall not
prevent the Executive from earning a livelihood upon the termination of employment hereunder, but
merely prevents unfair competition with the WellCare Companies for a limited period of time.

(c) Severability. The covenants in this Section 8 are severable and separate, and the
unenforceability of any specific covenant shall not affect the provisions of any other covenant.
In the event any court of competent jurisdiction shall determine that the scope, time or
territorial restrictions set forth herein are unreasonable, then it is the intention of the parties
that such restrictions be enforced to the fullest extent that such court deems reasonable, and this
Agreement shall thereby be reformed.

(d) Enforcement by the Company not Limited. All of the covenants in this Section 8
shall be construed as an agreement independent of any other provision in this Agreement, and the
existence of any claim or cause of action of the Executive against any WellCare Company, whether
predicated in this Agreement or otherwise, shall not constitute a defense to the enforcement by the
Company or WellCare of such covenants.

(e) Delivery of a Notice of Non-Renewal by the Company. Notwithstanding any other
provision contained herein, if the Employment Period ends as a result of the delivery of a Notice
of Non-Renewal to the Executive by the Company, then the provisions of clause (i) of Section 8(a)
hereof shall not apply to the Executive during the one-year period beginning on the last day of the
Employment Period unless the Company, in its sole discretion, elects, by delivery of a written
notice (a “Non-Compete Extension Notice”) to the Executive by no later than the last day of the
Employment Period, to keep such provisions of clause (i) of Section 8(a) hereof in effect for such
one-year period, in which case, as a result of the Company’s valid delivery of such a Non-Compete
Extension Notice to the Executive (and under no other circumstances), the Company shall be
obligated to pay to Executive his Base Salary during such one-year period.

9. Breach of Restrictive Covenants.

The parties agree that a breach or violation of Sections 6, 7 or 8 hereof will result in
immediate and irreparable injury and harm to the innocent party, and that such innocent party shall
have, in addition to any and all remedies of law and other consequences under this Agreement, the
right to seek an injunction, specific performance or other equitable relief to prevent the
violation of the obligations hereunder.

10. Notices.

For the purposes of this Agreement, notices, demands and all other communications provided for
in this Agreement shall be in writing and shall be deemed to have been duly given when delivered or
(unless otherwise specified) mailed by United States certified or registered mail, return receipt
requested, postage prepaid, addressed as follows:

(a) If to WellCare or the Company:

WellCare Health Plans, Inc.

8735 Henderson Road

Renaissance Two

Tampa, FL 33634

Attention: General Counsel

Fax: (813) 290-6210

(b) If to the Executive:

at the Executive’s last address or telecopy

number on the records of the Company

or to such other respective addresses as the parties hereto shall designate to the other by like
notice, provided that notice of a change of address shall be effective only upon receipt thereof.

11. Non-Assignment; Successors.

No party hereto may assign any rights or delegate any duties under this Agreement without the
prior written consent of the other parties hereto; provided, however, that: (i)
this Agreement shall inure to the benefit of and be binding upon the successors and assigns of the
Company and WellCare; and (ii) this Agreement shall inure to the benefit of and be binding upon the
heirs, assigns or designees of the Executive to the extent of any payments due to them hereunder.
As used in this Agreement, the term “Company” shall be deemed to refer to any such successor or
assign of the Company referred to in the preceding sentence.

12. Withholding of Taxes.

All payments required to be made by the Company to the Executive under this Agreement shall be
subject to the withholding of such amounts, if any, relating to tax, and other payroll deductions
as the Company may reasonably determine it should withhold pursuant to any applicable law or
regulation.

13. Payments; Mitigation.

All amounts payable by the Company to the Executive under this Agreement shall be paid
promptly on the dates required for such payment in this Agreement without notice or demand. The
Executive shall not be obligated to seek other employment in mitigation of the amounts payable or
the arrangements made under any provision of this Agreement, and, except as specifically provided
herein, any such employment obtained by the Executive shall not reduce or affect the amounts
payable or the arrangements made under any provision of this Agreement.

To the extent the Executive would otherwise be entitled to any payment (whether pursuant to
this Agreement or otherwise) during the six months beginning on termination of employment that
would be subject to the additional tax imposed under Section 409A of the Code (“Section 409A”), (i)
the payment will not be made to the Executive and instead will be made to a trust in compliance
with Revenue Procedure 92-64 (the “Rabbi Trust”) and (ii) the payment, together with earnings on
it, will be paid to the Executive on the earlier of the six-month anniversary of the Executive’s
date of termination of employment or the Executive’s death or disability (within the meaning of
Section 409A). Similarly, to the extent the Executive would otherwise be entitled to any benefit
(other than a payment) during the six months beginning on termination of employment that would be
subject to the Section 409A additional tax, the benefit will be delayed and will begin being
provided (together, if applicable, with an adjustment to compensate the Executive for the delay) on
the earlier of the six-month anniversary of the date of termination, death or disability (within
the meaning of Section 409A).

The Company will not take any action that would expose any payment or benefit to the Executive
to the additional tax of Section 409A, unless (i) the Company is obligated to take the action under
an agreement, plan or arrangement to which the Executive is a party, (ii) the Executive requests
the action, (iii) the Company advises the Executive in writing that the action may result in the
imposition of the additional tax and (iv) the Executive subsequently requests the action in a
writing that acknowledges the Executive will be responsible for any effect of the action under
Section 409A. The Company will hold the Executive harmless for any action it may take in violation
of this paragraph, including any attorney’s fees the Executive may incur in enforcing his rights.

It is the Company’s intention that the benefits and rights to which the Executive could become
entitled in connection with termination of employment comply with Section 409A. If the Executive
or the Company believes, at any time, that any of such benefit or right does not comply, it will
promptly advise the other and will negotiate reasonably and in good faith to amend the terms of
such arrangement such that it complies (with the most limited possible economic effect on the
Executive and on the Company).

14. Director and Officer Insurance.

During the Employment Period and, to the extent reasonably available, for a period of six (6)
years after the Executive ceases to be a director or officer of the Company, the Company shall use
its best efforts to obtain and maintain director’s and officer’s insurance for the Executive (in
such amounts as are appropriate for executives of businesses comparable to that of WellCare) and
shall give timely notice to the Executive of termination of any such insurance policy.

15. Indemnification.

The Company and WellCare shall indemnify the Executive, in his capacity as an officer of the
Company and WellCare, to fullest extent permitted under the Company’s and WellCare’s respective
By-Laws (not including any amendments or additions hereafter that limit or narrow, but including
any that add to or broaden, the protection afforded to the Executive by those provisions) and
applicable law. This provision shall survive the termination of this Agreement.

If any contest or dispute shall arise involving the failure or refusal of the Company to
perform fully in accordance with the terms hereof after a Change in Control or to provide any other
benefit to the Executive pursuant to any compensatory arrangement, the Company shall reimburse the
Executive, on a current basis, for all reasonable legal fees and expenses, if any, incurred by
Executive in connection with such contest or dispute, together with interest in an amount equal to
the then-current prime rate as reported in The Wall Street Journal, such interest to be determined
and to accrue (if payment is not received by the Executive within thirty (30) days) from the date
the Company receives Executive’s statement for such fees and expenses through the date of payment
thereof, regardless of whether or not Executive’s claim is upheld by a court of competent
jurisdiction; provided, however, the Executive shall be required to repay any such
amounts to the Company if the Executive fails to prevail with respect to at least one material
claim asserted by the Executive in such contest or dispute.

16. Waiver of Breach.

Any waiver of any breach of this Agreement shall not be construed to be a continuing waiver or
consent to any subsequent breach on the part either of the Executive or of the Company or WellCare.

17. Severability.

To the extent any provision of this Agreement or portion thereof shall be invalid or
unenforceable, including, without limitation, Sections 6, 7 and 8 hereof, the specific provision
found invalid or unenforceable shall be considered deleted therefrom to the extent invalid and/or
unenforceable and the remainder of such provision and of this Agreement shall be unaffected and
shall continue in full force and effect.

18. Governing Law.

This Agreement shall be construed, interpreted and enforced in accordance with the laws of the
State of New York, without giving effect to the choice of law provisions thereof.

19. Complete Agreement.

This Agreement constitutes the entire agreement by WellCare, the Company and the Executive
with respect to the subject matter hereof and supersedes any and all prior agreements or
understandings between the Executive and the WellCare Companies with respect to the subject matter
hereof, including any employment agreements, arrangements or understandings existing or that arose
prior to the Effective Date, whether written or oral, including without limitation the Original
Employment Agreement. This Agreement may be amended or modified only by a written instrument
executed by the Executive, WellCare and the Company (with the prior approval of the Board).

20. Counterparts.

This Agreement may be executed in one or more counterparts, each of which shall be deemed to
be an original but all of which together will constitute one and the same instrument.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

1

IN WITNESS WHEREOF, the parties have executed this Amended and Restated Employment
Agreement as of the date first written above.

	 
	 

	WELLCARE:

	 

	WELLCARE HEALTH PLANS, INC.

By:

	Name:

	Its:

	COMPANY:

	 

	COMPREHENSIVE HEALTH MANAGEMENT, INC.

By:

	Name:

	Its:

	 

	EXECUTIVE:

	 

	Todd S. Farha

	 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]